Cosentyx vs Januvia
Side-by-side drug price comparison from Medicare Part D data
Verdict
Januvia costs 94% less per claim than Cosentyx ($219.00 vs $3616.00). Cosentyx has a generic alternative available. Total Medicare spending: Cosentyx at $3.1B vs Januvia at $2.7B.
| Metric | Cosentyx | Januvia |
|---|---|---|
| Avg Cost per Claim Average cost Medicare pays per prescription claim | $3,616 | $219* |
| Total Medicare Spending Total Medicare Part D spending on this drug | $3.1B | $2.7B |
| Total Claims | 864,000 | 12,480,000 |
| Year-over-Year Change Price change from prior year (lower is better for patients) | 8.9% | -12.3%* |
| Generic Available | Yes | No |
| Condition | Autoimmune Diseases | Diabetes |
| Total Beneficiaries | 120,000 | 1,560,000 |
Januvia costs 94% less per claim than Cosentyx ($219.00 vs $3616.00). Cosentyx has a generic alternative available. Total Medicare spending: Cosentyx at $3.1B vs Januvia at $2.7B.
Explore More
Comparing Cosentyx and Januvia on U.S. Medicare prescription-drug pricing requires lining up the underlying CMS Medicare Part D Drug Spending data data side by side. The table above runs the comparison on the canonical fields; the narrative below identifies the factor or factors that drive the most meaningful difference between the two.
For households or analysts using this comparison as a decision input, the right framing is usually not "which is better" in aggregate but "which is better for the specific decision in front of you." CMS Medicare Part D Drug Spending data captures the raw data; the framing depends on whether the question is investment, residency, planning, or research.
Source: CMS Medicare Part D Spending, 2026.